www.fdanews.com/articles/96914-biovail-enters-into-license-and-development-agreement
Biovail Enters Into License and Development Agreement
August 8, 2007
Biovail Corporation announced that a subsidiary, Biovail Laboratories International SRL, has entered into a license and development agreement with an undisclosed, privately held, drug-development company for the exclusive global rights to BVF-324, a novel product for the treatment of a prevalent sexual dysfunction.
Biovail